Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,642 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A Case of Advanced Submandibular Gland Cancer in Which Increased Prostate-Specific Antigen and Multiple Bone Metastases Wrongly Suggested Concurrent Prostate Cancer.
Fukasawa Y, Honda T, Natsume M, Haruyama T, Ishihara M, Sakamoto T, Usui R, Tanzawa S, Ota S, Ichikawa Y, Watanabe K, Saito K, Seki N. Fukasawa Y, et al. Among authors: ota s. Case Rep Oncol. 2017 Dec 20;10(3):1127-1130. doi: 10.1159/000484975. eCollection 2017 Sep-Dec. Case Rep Oncol. 2017. PMID: 29430238 Free PMC article.
A Case of Lung Adenocarcinoma with Marked Improvement of Pulmonary Lymphangitic Carcinomatosis by Adding Bevacizumab to Cisplatin and Pemetrexed.
Natsume M, Honda T, Haruyama T, Ishihara M, Fukasawa Y, Sakamoto T, Tanzawa S, Usui R, Ota S, Ichikawa Y, Watanabe K, Seki N. Natsume M, et al. Among authors: ota s. Case Rep Oncol. 2017 Nov 27;10(3):1065-1069. doi: 10.1159/000484662. eCollection 2017 Sep-Dec. Case Rep Oncol. 2017. PMID: 29515397 Free PMC article.
Significance of Earlier Initiation of Chemotherapy for Lung Cancer Complicated with Primary or Secondary Nephrotic Syndrome following Its Appropriate Differential Diagnosis.
Ota S, Fujigaki Y, Tamura Y, Kojima K, Ochiai R, Haruyama T, Ishihara M, Natsume M, Fukasawa Y, Sakamoto T, Tanzawa S, Usui R, Honda T, Ichikawa Y, Watanabe K, Seki N. Ota S, et al. Case Rep Oncol. 2019 Jan 11;12(1):53-58. doi: 10.1159/000493851. eCollection 2019 Jan-Apr. Case Rep Oncol. 2019. PMID: 30792645 Free PMC article.
Need for Flexible Adjustment of the Treatment Schedule for Aprepitant Administration against Erlotinib-Induced Refractory Pruritus and Skin Rush.
Seki N, Ochiai R, Haruyama T, Ishihara M, Natsume M, Fukasawa Y, Sakamoto T, Tanzawa S, Usui R, Honda T, Ota S, Ichikawa Y, Watanabe K. Seki N, et al. Among authors: ota s. Case Rep Oncol. 2019 Jan 21;12(1):84-90. doi: 10.1159/000493256. eCollection 2019 Jan-Apr. Case Rep Oncol. 2019. PMID: 30792647 Free PMC article.
Promising Combination Therapy with Bevacizumab and Erlotinib in an EGFR-Mutated NSCLC Patient with MET Amplification Who Showed Intrinsic Resistance to Initial EGFR-TKI Therapy.
Seki N, Natsume M, Ochiai R, Haruyama T, Ishihara M, Fukasawa Y, Sakamoto T, Tanzawa S, Usui R, Honda T, Ota S, Ichikawa Y, Watanabe K. Seki N, et al. Among authors: ota s. Case Rep Oncol. 2019 Jan 21;12(1):91-97. doi: 10.1159/000493088. eCollection 2019 Jan-Apr. Case Rep Oncol. 2019. PMID: 30792648 Free PMC article.
Nivolumab-Induced Myocarditis Concomitant with Myasthenia Gravis.
Fukasawa Y, Sasaki K, Natsume M, Nakashima M, Ota S, Watanabe K, Takahashi Y, Kondo F, Kozuma K, Seki N. Fukasawa Y, et al. Among authors: ota s. Case Rep Oncol. 2017 Sep 6;10(3):809-812. doi: 10.1159/000479958. eCollection 2017 Sep-Dec. Case Rep Oncol. 2017. PMID: 29070994 Free PMC article.
1,642 results